Evidence map›Paper›PMID 42873009›Full record

ReviewNanomaterials (Basel, Switzerland)2026

Doped Non-Ti MXenes for Supercapacitor Applications.

Ramaswamy Sandeep Perala, Radha Gupta, Chandan Kumar Maity

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ramaswamy Sandeep PeralaDepartment of Chemistry, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 13120, Republic of Korea.ORCID 0000-0001-6042-5412
Radha GuptaCenter for Multidimensional Carbon Materials (CMCM), Institute for Basic Science (IBS), Ulsan 44919, Republic of Korea.
Chandan Kumar MaityDepartment of Chemistry, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 13120, Republic of Korea.ORCID 0000-0003-2675-9149

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid development of high-performing energy storage technologies has increased the search for 2D electrode materials with tunable electronic structures, abundant electroactive sites, and rapid ion transportation. Although Ti-based MXenes have been extensively investigated, non-Ti MXenes offer a broader compositional space and distinctive physicochemical properties, yet their supercapacitor applications remain comparatively underexplored. In this review, we critically examine the emerging field of doped non-Ti MXenes for advanced supercapacitor applications, including Mo-, V-, Nb-, Cr-, W-, Zr-, Hf-, Ta-, Sc-, and Y-based systems. In this review, we establish the structural, chemical, and electrochemical characteristics of non-Ti MXenes and subsequently discuss M-, X-, and T-site doping, substitution, and multielement engineering strategies. We have discussed how heteroatom doping regulates electronic structure, charge distribution, defect chemistry, interlayer spacing, surface chemistry, and ion-accessible active sites. These modifications are correlated with their influence on electrochemical kinetics, capacitance, rate capability, and cyclic stability. Finally, computational and data-driven approaches, critical benchmarking, and critical challenges are integrated to establish structure-doping-mechanism-performance relationships and design principles for next-generation doped non-Ti MXene electrodes for supercapacitors.

Indexed as

defect chemistrydoped non-Ti MXeneselectronic structureheteroatom dopingstructure–performance relationshipssupercapacitors

Identifiers

PMID42873009
PMCPMC13666835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.